Neuromodulation for metabolic conditions or syndromes
US10617460B2 · kind B2 · utility
5Cited by
351References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2019 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | Sep 6, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N7/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.